Innate Pharma IPHA
NASDAQ IPHA
$2.26 +0.17 (+8.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Innate Pharma (IPHA) Debt Ratio (2017 - 2025)

Innate Pharma's (IPHA) quarterly Debt Ratio came in at 0.36 in Q4 2025, up 28.96% YoY from 0.28 in Q4 2024, and up 23.75% on a QoQ basis from 0.29 in Q2 2025.

Innate Pharma (IPHA) Debt Ratio (2017 - 2025) Analysis & Trends

Innate Pharma (IPHA) has 9 years of Debt Ratio data on file, last reported at 0.36 in Q4 2025.

  • Quarterly Debt Ratio rose 28.96% year-over-year to 0.36 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.36 (up 28.96% YoY) and the FY2025 annual result came in at 0.5, up 39.93% from the prior year.
  • Debt Ratio climbed to 0.36 in Q4 2025, from 0.29 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.36 in Q4 2025 to a low of 0.06 in Q2 2021.
  • A 5-year average of 0.23 and a median of 0.23 in 2022 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 265.63% — and 2023, when it decreased 9.87%.
  • Tracing IPHA's Debt Ratio over 5 years: stood at 0.17 in 2021, then increased by 28.15% to 0.21 in 2022, then advanced by 7.41% to 0.23 in 2023, then gained by 22.56% to 0.28 in 2024, then increased by 28.96% to 0.36 in 2025.
  • The last three Debt Ratio figures came in at 0.36 (Q4 2025), 0.29 (Q2 2025), and 0.28 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Innate Pharma 202.03 Mn 202.03 Mn - 0.36

Historic Data

Download Data
DateValue
Dec 31, 2025 0.36
Jun 30, 2025 0.29
Dec 31, 2024 0.28
Jun 30, 2024 0.23
Dec 31, 2023 0.23
Jun 30, 2023 0.20
Dec 31, 2022 0.21
Jun 30, 2022 0.23
Dec 31, 2021 0.17
Jun 30, 2021 0.06
Dec 31, 2020 0.06
Jun 30, 2020 0.06
Dec 31, 2019 0.05
Dec 31, 2018 0.01
Dec 31, 2017 0.02